学术探索
学术期刊
新闻热点
数据分析
智能评审

THE RISK OF CYTOMEGALOVIRUS-INFECTION IN SOLID ORGAN AND BONE-MARROW TRANSPLANT RECIPIENTS - TRANSFUSION OF BLOOD PRODUCTS

被引：47
作者：
HILLYER, CD
SNYDMAN, DR
BERKMAN, EM
机构：
[1] TUFTS UNIV,NEW ENGLAND MED CTR HOSP,SCH MED,DEPT MED,DIV HEMATOL ONCOL,BOSTON,MA 02111
[2] TUFTS UNIV,NEW ENGLAND MED CTR HOSP,SCH MED,DEPT PATHOL,BOSTON,MA 02111
[3] TUFTS UNIV,NEW ENGLAND MED CTR HOSP,SCH MED,DEPT CLIN MICROBIOL,BOSTON,MA 02111
[4] TUFTS UNIV,NEW ENGLAND MED CTR HOSP,SCH MED,DIV GEOG MED INFECT DIS,BOSTON,MA 02111
来源：
TRANSFUSION | 1990年 / 30卷 / 07期
关键词：
D O I：
10.1046/j.1537-2995.1990.30790385528.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：659 / 666
页数：8
相关论文
共 88 条
  • [51] SUBCLINICAL CYTOMEGALOVIRUS INFECTIONS AND CYTOMEGALOVIRUS MONONUCLEOSIS AFTER OPEN HEART SURGERY
    PALOHEIMO, JA
    VONESSEN, R
    KLEMOLA, E
    KAARIAINEN, L
    SILTANEN, P
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1968, 22 (05) : 624 - +
  • [52] INTERSTITIAL PNEUMONITIS FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    PECEGO, R
    HILL, R
    APPELBAUM, FR
    AMOS, D
    BUCKNER, CD
    FEFER, A
    THOMAS, ED
    [J]. TRANSPLANTATION, 1986, 42 (05) : 515 - 517
  • [53] A PROSPECTIVE-STUDY OF INFECTIOUS-DISEASES FOLLOWING BONE-MARROW TRANSPLANTATION - EMERGENCE OF ASPERGILLUS AND CYTOMEGALOVIRUS AS THE MAJOR CAUSES OF MORTALITY
    PETERSON, PK
    MCGLAVE, P
    RAMSAY, NKC
    RHAME, F
    COHEN, E
    PERRY, GS
    GOLDMAN, AI
    KERSEY, J
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1983, 4 (02) : 81 - 89
  • [54] COMPARISON OF 5 METHODS OF CYTOMEGALOVIRUS ANTIBODY SCREENING OF BLOOD-DONORS
    PHIPPS, PH
    GREGOIRE, L
    ROSSIER, E
    PERRY, E
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1983, 18 (06) : 1296 - 1300
  • [55] POLLICE MA, 1987, 27TH INT C ANT AG CH
  • [56] INFECTIONS DUE TO HERPESVIRUSES IN CARDIAC TRANSPLANT RECIPIENTS - ROLE OF THE DONOR HEART AND IMMUNOSUPPRESSIVE THERAPY
    PREIKSAITIS, JK
    ROSNO, S
    GRUMET, C
    MERIGAN, TC
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1983, 147 (06) : 974 - 981
  • [57] THE RISK OF CYTOMEGALO-VIRUS INFECTION IN SERONEGATIVE TRANSFUSION RECIPIENTS NOT RECEIVING EXOGENOUS IMMUNOSUPPRESSION
    PREIKSAITIS, JK
    BROWN, L
    MCKENZIE, M
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1988, 157 (03) : 523 - 529
  • [58] SEROLOGIC STUDY OF CYTOMEGALOVIRUS INFECTIONS ASSOCIATED WITH BLOOD TRANSFUSIONS
    PRINCE, AM
    SZMUNESS, W
    MILLIAN, SJ
    DAVID, DS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1971, 284 (20) : 1125 - &
  • [59] INACTIVATION OF VIRUS IN BLOOD PRODUCTS
    PRODOUZ, KN
    FRATANTONI, JC
    [J]. TRANSFUSION, 1988, 28 (01) : 2 - 3
  • [60] CYTO-TOXIC T-CELLS IN CYTOMEGALOVIRUS-INFECTION - HLA-RESTRICTED LYMPHOCYTE-T AND NON-T-LYMPHOCYTE CYTO-TOXIC RESPONSES CORRELATE WITH RECOVERY FROM CYTOMEGALOVIRUS-INFECTION IN BONE-MARROW-TRANSPLANT RECIPIENTS
    QUINNAN, GV
    KIRMANI, N
    ROOK, AH
    MANISCHEWITZ, JF
    JACKSON, L
    MORESCHI, G
    SANTOS, GW
    SARAL, R
    BURNS, WH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (01) : 7 - 13
123456789